Aliskiren
Signals from filings dated May 2026 – May 2026 · Last checked 15 Nov 2026
Supply outlook
↓ SHRINKINGIn the filings we track: 0 plants adding this molecule, 1 exit signal, 0 intermediate projects.
Signals
Tonghai 4th Road No. 2, Yangkou Chemical Industrial Park (West), Rudong, Nantong, Jiangsu
- ✓ EIA filed
- ✓ Approval notice
- ✓ EIA approved · 8 May 2026
- Next: completion check
- DMF / CEP
The existing aliskiren line (3.9 t/yr) is removed. The plant adds 33 t/yr of anti-inflammatory and anti-tumour APIs and 16 t/yr of CDMO APIs; the approval does not name those molecules. Approval No. 通数据审批〔2026〕130号, 8 May 2026. Source: EIA approval, Nantong Data Bureau
Who makes Aliskiren today: 13 listings
Current manufacturers with US DMF and CEP status, plant addresses and contacts.
| Manufacturer | Country | US DMF | CEP | Contact |
|---|---|---|---|---|
| CHANGZHOU PHARMACEUTICAL FACTORY | China | ✓ | — | In database |
| Nosch Labs Pvt Ltd | India | ✓ | — | In database |
| Tecoland Corp. | United States | — | — | In database |
| + 10 more listings in api-fdf.com → | ||||
Three examples from the api-fdf.com database, refreshed weekly. Plant addresses and contacts are shown in the database.
Follow Aliskiren
Get an email when a new filing adds, cuts or moves this molecule to the next stage.